Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Vaccination of chickens with a combination vaccine against infectious LT and FP disease.

Proposed period of release:
25/09/2013 to 31/12/2015

Name of the Institute(s) or Company(ies)
CEVA Salud Animal, S.A., C/ Carabela La NiƱa, 12
08017 Barcelona, Spain;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Vectormune FP-LT is a modified Fowlpox virus expressing the gB and UL-32 genes of laryngotracheitis virus as well as the LacZ gene of E. coli. Fowlpox virus (FPV) is classified in the family Poxviridae in the genus Avipoxvirus. It is the active ingredient of Vectormune FP-LT, a live freeze dried vaccine for chickens against fowlpox and infectious laryngotracheitis.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
FPVAvipox virus--Cutter strain-

European Commission administrative information

Consent given by the Member State Competent Authority:
21/04/2014 00:00:00